However, the transition was significantly less common in HER2-E tumours of the ER+/HER2+ subset, where only 14% shifted to LumA after AI treatment, compared to a 50% transition in the POETIC ER+/HER2− group. This evidence concerns the gene ERBB2 and neoplasm.